Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
NCT ID: NCT03761758
Last Updated: 2018-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2018-05-01
2018-07-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Control of Myopia Using Novel Spectacle Lens Designs
NCT03623074
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NCT06034327
A Randomized Clinical Trial on the Effectiveness of Novel Plano Spectacle Lenses on Myopia Prevention in Pre-myopic Children
NCT06860737
Peripheral Optics in Myopia and Orthokeratology
NCT00978679
Assessment of Bifocal and Prismatic Bifocal Spectacles for Myopia Control in Children
NCT00787579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DEVICE_FEASIBILITY
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lens Design 1
Spectacle lenses design 1, fitted into spectacle frames
Spectacle lenses
Spectacle lenses with clear central apertures
Lens Design 2
Spectacle lenses design 2, fitted into spectacle frames
Spectacle lenses
Spectacle lenses with clear central apertures
Lens Design 3
Spectacle lenses design 3, fitted into spectacle frames
Spectacle lenses
Spectacle lenses with clear central apertures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spectacle lenses
Spectacle lenses with clear central apertures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myopia between -1.00 and -4.00 D
Exclusion Criteria
* Contact lens wearer
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SightGlass Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joe Rappon, OD, MS
Role: STUDY_DIRECTOR
SightGlass Vision
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Ocular Research & Education
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/639/18/SG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.